Optimization of curcumin loaded vaginal in-situ hydrogel by boxbehnken statistical design for contraception

Journal of Drug Delivery Science and Technology

Volumn 29, Issue , 2015, Pages 55-69

  Patel, Nirav ^a   Thakkar, Vaishali ^b   Moradiya, Parita ^b   Gandhi, Tejal ^b   Gohel, Mukesh ^b  

^a SAURASHTRA UNIVERSITY   (India)

^b ANAND PHARMACY COLLEGE   (India)

Author keywords

Box behnken statistical design; Contraception; Curcumin; Poloxamer; Vaginal in situ hydrogel

Indexed keywords

CONTRACEPTIVE AGENT; CURCUMIN; POLOXAMER;

ARTICLE; CONTRACEPTION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; EXPERIMENTAL DESIGN; GELATION; HUMAN; HYDROGEL; IMMOBILIZATION; INFRARED SPECTROSCOPY; MALE; NORMAL HUMAN; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; SPERM; STATISTICAL ANALYSIS; STRENGTH; TEMPERATURE; VISCOSITY;

EID: 84942310771     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jddst.2015.06.002     Document Type: Article

References (61)

1. J. Seltzer, The Origins and Evolution of Family Planning Programs in Developing Countries, Rand, Santa Monica, CA, 2002.
2. D. Gould, Contraception: the changing needs of women throughout the reproductive years, Nurs. Stand. 14 (2000) 37-43.
3. I. Askew, M. Brady, The Unfinished Agenda to Meet FP2020 Goals, Population Council, New York, 2013.
4. P. Harrison, A. Rosenfield, Contraceptive Research and Development, National Academy Press, Washington, D.C, 1996.
5. F. Uckun, Prophylactic contraceptives for HIV/AIDS, Hum. Reprod. Update 5 (1999) 506-514.
6. R. Roddy, L. Zekeng, K. Ryan, U. Tamoufe, S. Weir, E. Wong, A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases, J Urology (1999) 1422-1423.
7. J. Kreiss, Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes, JAMA: the J of the Ame, Med. Assoc. 268 (1992) 477-482.
8. Nonoxynol-9 and the reduction of HIV transmission in women, AIDS 6 (1992) 599-600.
9. V. Gupta, Comprehensive Bioactive Natural Products, Stadium Press, Texas, 2010.
10. R. Naz, M. Lough, Curcumin as a potential non-steroidal contraceptive with spermicidal and microbicidal properties, Eur. J. Obstet. Gyn R. B 176 (2014) 142-148.
11. A. Mazumder, K. Raghavan, J. Weinstein, K. Kohn, Y. Pommier, Inhibition of human immunodeficiency virus type-1 integrase by curcumin, Biochem. Pharmacol. 49 (1995) 1165-1170.
12. S. Sood, M. Nagpal, Role of curcumin in systemic and oral health: an overview, J Nat Sci, Bio Med 4 (2013) 3-6.
13. T. Rithaporn, M. Monga, M. Rajasekaran, Curcumin: a potential vaginal contraceptive, Contraception 68 (2003) 219-223.
14. R. Sharma, A. Gescher, W. Steward, Curcumin: the story so far, Eur. J. Cancer 41 (2005) 1955-1968.
15. P. Basnet, N. Skalko-Basnet, Curcumin: a Challenge in Cancer treatment, J. Nepal Pharm. Assoc. (2012) 26-28.
16. K. Berginc, N.A. kalko-Basnet, P. Basnet, A. Kristl, Development and evaluation of an in vitro vaginal model for assessment of drugs biopharmaceutical properties: curcumin, AAPS Pharmscitech 13 (2012) 1045-1053.
17. P. Basnet, H. Hussain, I. Tho, N. Skalko-Basnet, Liposomal delivery system enhances anti-inflammatory properties of curcumin, J. Pharm. Sci. 101 (2011) 598-609.
18. K. Knuth, M. Amiji, J. Robinson, Hydrogel delivery systems for vaginal and oral applications, Adv. Drug Deliv. Rev. 11 (1993) 137-167.
19. S. Karavana, S. Renbe, Z. Azenyit, E. Baloaylu, A new in-situ gel formulation of itraconazole for vaginal administration 03 (2012) 417-426.
20. K. Bouchemal, A. Aka-Any-Grah, N. Dereuddre-Bosquet, et al., Thermosensitive and mucoadhesive pluronic-hydroxypropylmethylcellulose hydrogel containing the mini-CD4 M48U1 is a promising efficient barrier against HIV diffusion through macaque cervicovaginal mucus, Antimicrob. Agents Ch 59 (2015) 2215-2222.
21. E. Ibrahim, S. Ismail, G. Fetih, O. Shaaban, K. Hassanein, N. Abdellah, Development and characterization of thermosensitive pluronic-based metronidazole in situ gelling formulations for vaginal application, Acta Pharm. 62 (2012) 59-70.
22. A. El-Kamel, M. El-Khatib, Thermally reversible in situ gelling carbamazepine liquid suppository, Drug Deliv. 13 (2006) 143-148.
23. G. Fetih, D. Fathalla, M. El-Badry, Liposomal gels for site-specific, sustained delivery of Celecoxib: In vitro and in vivo evaluation, Drug Dev. Res. 75 (2014) 257-266.
24. Y. Qian, F. Wang, R. Li, Q. Zhang, Q. Xu, Preparation and evaluation of in situ gelling ophthalmic drug delivery system for methazolamide, Drug Dev. Ind. Pharm. 36 (2010) 1340-1347. http://ftp.fao.org/es/esn/jecfa/cta/CTA-61-Curcumin.pdf
25. http://ftp.fao.org/es/esn/jecfa/cta/CTA-61-Curcumin.pdf
26. R. Naz, Can curcumin provide an ideal contraceptive? Mol. Reprod. Dev. 78 (2011) 116-123.
27. S. Chopra, S. Motwani, Z. Iqbal, S. Talegaonkar, F. Ahmad, R. Khar, Optimisation of polyherbal gels for vaginal drug delivery by Box-Behnken statistical design, Eur. J. Pharm. Biopharm. 67 (2007) 120-131.
28. N. Patel, J. Patel, S. Shah, Box-Behnken experimental design in the development of pectin-compritol ATO 888 compression coated colon targeted drug delivery of mesalamine, Acta Pharm. 60 (2010) 39-54.
29. R. Narayana, N. Harish, A.M. Gulzar, P. Prabhakara, A. Singh, E. Subrahmanyam, Formulation and in vitro evaluation of in situ gels containing secnidazole for vaginitis, Yakugaku Zasshi 129 (2009) 569-574.
30. Y. Han, M. Singh, B. Saxena, Development of vaginal rings for sustained release of nonhormonal contraceptives and anti-HIV agents, Contraception 76 (2007) 132-138.
31. B. Saxena, M. Singh, R. Gospin, C. Chu, W. Ledger, Efficacy of nonhormonal vaginal contraceptives from a hydrogel delivery system, Contraception 70 (2004) 213-219.
32. M. Godley, Quantitation of vaginal discharge in healthy volunteers, Brit J. Obstet. Gynaec 92 (1985) 739-742.
33. G. Wagner, R. Levin, Electrolytes in vaginal fluid during the menstrual cycle of coitally active and inactive women, Reproduction 60 (1980) 17-27.
34. C. Niederberger, Re: age thresholds for changes in semen parameters in men, J Uro 191 (2014) 1356.
35. F. Lotti, G. Corona, E. Maseroli, et al., Clinical implications of measuring prolactin levels in males of infertile couples. Andrology 1 (2013) 764-771.
36. D. Owen, D. Katz, A vaginal fluid simulant, Contraception 59 (1999) 91-95.
37. D. Owen, A review of the physical and chemical properties of human semen and the formulation of a semen simulant, J. Androl. 26 (2005) 459-469.
38. R. Shah, D. Patel, M. Mehta, C. Patel, Design and optimization of mucoadhesive nasal in situ gel containing sodium cromoglycate using factorial design, Asian J. Pharm. 5 (2011) 65-74.
39. Y. Yuan, Y. Cui, L. Zhang, H.P. Zhu, et al., Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide, Int. J. Pharm. 430 (2012) 114-119.
40. Y. Han, M. Singh, B. Saxena, Development of vaginal rings for sustained release of nonhormonal contraceptives and anti-HIV agents, Contraception 76 (2007) 132-138.
41. B. Saxena, M. Singh, R. Gospin, C. Chu, W. Ledger, Efficacy of nonhormonal vaginal contraceptives from a hydrogel delivery system, Contraception 70 (2004) 213-219.
42. http://Sperm testing for Male Infertility, (Sperm Count, Motility & Morphology).
43. http://en.wikipedia.org/wiki/Female-ejaculation.
44. http://en.wikipedia.org/wiki/Male-ejaculation.
45. W. Ford, Comments on the release of the 5th edition of the WHO laboratory manual for the examination and processing of human Semen, Asian J And 12 (2010) 59-63.
46. D. Paul, S. Bera, D. Jana, R. Maiti, D. Ghosh, In vitro determination of the contraceptive spermicidal activity of a composite extract of Achyranthes aspera and stephania hernandifolia on human semen, Contraception 73 (2006) 284-288.
47. Who laboratory manual for the examination of human semen and spermcervical mucus interaction, Int. J. Androl. 19 (1996) 149-150.
48. H. Shah, K. Singh, P. Tatke, Spermicidal agents, Drug Discov. Ther. 2 (2015) 200-210.
49. R. De Lisi, S. Milioto, N. Muratore, Binding of short alkyl chain surfactants to the (Ethylene oxide)13-(Propylene oxide)30-(Ethylene oxide)13 and (Ethylene oxide)75-(Propylene oxide)30-(Ethylene oxide)75 copolymers studied by microcalorimetry, Macromolecules 35 (2002) 7067e7073.
50. S. Elzanaty, J. Malm, Effects of ejaculation-to-analysis delay on levels of markers of epididymal and accessory sex gland functions and sperm motility, J Andro 28 (2007) 847-852.
51. O. Dacruz, S. Yiv, F. Uckun, GM-144, a novel lipophilic vaginal contraceptive gel-microemulsion, AAPS Pharmscitech 2 (2001) 4-13.
52. H. Izumi, T. Marian, K. Inaba, Y. Oka, M. Morisawa, Membrane hyperpolarization by sperm-activating and -Attracting factor increases cAMP level and activates sperm motility in the ascidian ciona intestinalis, Dev. Biol. 213 (1999) 246-256.
53. C. Bosetti, C. La Vecchia, Long-term oral contraceptive use increased the risk of cervical cancer in HPV-positive women, Evidence-Based Obstetrics Gynecol. 4 (2002) 205-206.
54. U. Hani, R. Bhat, R. Sisodiya, H. Gurumallappa Shivakumar, Novel vaginal drug delivery systems: a review, Curr. Drug Ther. 5 (2010) 95-104.
55. H. Shivakumar, C. Satish, K. Satish, Hydrogels as controlled drug delivery systems: synthesis, crosslinking, water and drug transport mechanism, Ind J Pharma Sci. 68 (2006) 133-140.
56. O. Vieira, D. Hartmann, C. Cardoso, et al., Surfactants as microbicides and contraceptive agents: a systematic in vitro study,, Plos ONE 3 (2008) e2913.
57. A. Aka-Any-Grah, K. Bouchemal, A. Koffi, et al., Formulation of mucoadhesive vaginal hydrogels insensitive to dilution with vaginal fluids, Eur. J. Pharm. Biopharm. 76 (2010) 296-303.
58. A. Cabana, A. Ait-Kadi, J. Juhasz, Study of the gelation process of polyethylene OxideaePolypropylene OxidebePolyethylene OxideaCopolymer (Poloxamer 407) aqueous solutions, J. Colloid Interf. Sci. 190 (1997) 307-312.
59. I. Tung, Rheological behavior of poloxamer 407 aqueous solutions during solgel and dehydration processes, Int. J. Pharm. 107 (1994) 85-90.
60. F. Acarturk, Mucoadhesive vaginal drug delivery systems, DDF 3 (2009) 193-205.
61. N. Lohiya, B. Manivannan, S. Goyal, A. Ansari, Sperm motility inhibitory effect of the benzene chromatographic fraction of the chloroform extract of the seeds of carica papaya in langur monkey, Presbytis entellus entellus, Asian J Andro 10 (2008) 298-306.